220 related articles for article (PubMed ID: 19291728)
1. Enzyme, substrate, and myeloma in Gaucher disease.
Hughes DA
Am J Hematol; 2009 Apr; 84(4):199-201. PubMed ID: 19291728
[No Abstract] [Full Text] [Related]
2. Gaucher disease: resetting the clinical and scientific agenda.
Mistry PK; Weinreb NJ; Brady RO; Grabowski GA
Am J Hematol; 2009 Apr; 84(4):205-7. PubMed ID: 19296473
[No Abstract] [Full Text] [Related]
3. The underrecognized progressive nature of N370S Gaucher disease and assessment of cancer risk in 403 patients.
Taddei TH; Kacena KA; Yang M; Yang R; Malhotra A; Boxer M; Aleck KA; Rennert G; Pastores GM; Mistry PK
Am J Hematol; 2009 Apr; 84(4):208-14. PubMed ID: 19260119
[TBL] [Abstract][Full Text] [Related]
4. Enzyme replacement therapy for mild patients with Gaucher disease.
Zimran A; Ilan Y; Elstein D
Am J Hematol; 2009 Apr; 84(4):202-4. PubMed ID: 19229987
[No Abstract] [Full Text] [Related]
5. Phenotypic and genotypic heterogeneity in Gaucher disease type 1: a comparison between Brazil and the rest of the world.
Sobreira E; Pires RF; Cizmarik M; Grabowski GA
Mol Genet Metab; 2007 Jan; 90(1):81-6. PubMed ID: 16996765
[TBL] [Abstract][Full Text] [Related]
6. Gaucher disease: complexity in a "simple" disorder.
Sidransky E
Mol Genet Metab; 2004; 83(1-2):6-15. PubMed ID: 15464415
[TBL] [Abstract][Full Text] [Related]
7. Identification of Gaucher disease mutations found in Saudi Arabia.
Kaya N; Al-Zahrani F; Al-Odaib A; Rahbeeni Z; Al-Hassnan Z; Al-Sharif F; Ozand P; Al-Sayed M
Blood Cells Mol Dis; 2008; 41(2):200-1. PubMed ID: 18586535
[No Abstract] [Full Text] [Related]
8. Vitamin D Receptor (VDR) polymorphic variants in patients with cancer and Gaucher disease.
Lieblich M; Altarescu G; Zimran A; Elstein D
Blood Cells Mol Dis; 2011 Jan; 46(1):92-4. PubMed ID: 20920864
[TBL] [Abstract][Full Text] [Related]
9. Sixteen years of prenatal consultations for the N370S/N370S Gaucher disease genotype: what have we learned?
Eitan Y; Abrahamov A; Phillips M; Elstein D; Zimran A
Prenat Diagn; 2010 Oct; 30(10):924-7. PubMed ID: 20721872
[TBL] [Abstract][Full Text] [Related]
10. Mutation analysis in Gaucher disease.
Beutler E; Gelbart T
Am J Med Genet; 1992 Oct; 44(3):389-90. PubMed ID: 1488994
[No Abstract] [Full Text] [Related]
11. [From gene to disease; Gaucher disease].
Hollak CE; Boot RG; Poorthuis BJ; Aerts JM
Ned Tijdschr Geneeskd; 2005 Sep; 149(39):2163-6. PubMed ID: 16223076
[TBL] [Abstract][Full Text] [Related]
12. The glucocerebrosidase locus in Gaucher's disease: molecular analysis of a lysosomal enzyme.
Mistry PK; Cox TM
J Med Genet; 1993 Nov; 30(11):889-94. PubMed ID: 8301642
[No Abstract] [Full Text] [Related]
13. The glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews.
Zimran A; Neudorfer O; Elstein D
N Engl J Med; 2005 Feb; 352(7):728-31; author reply 728-31. PubMed ID: 15719452
[No Abstract] [Full Text] [Related]
14. Molecular characterization of type 3 (neuronopathic) Gaucher disease in Thai patients.
Suwannarat P; Keeratichamroen S; Wattanasirichaigoon D; Ngiwsara L; Cairns JR; Svasti J; Visudtibhan A; Pangkanon S
Blood Cells Mol Dis; 2007; 39(3):348-52. PubMed ID: 17689991
[TBL] [Abstract][Full Text] [Related]
15. [Type 1 Gaucher disease in a pediatric patient: 12 year's evolution].
García M; Casanova C; Chabás A; Viosca E; Martínez B
Sangre (Barc); 1997 Jun; 42(3):227-9. PubMed ID: 9381267
[TBL] [Abstract][Full Text] [Related]
16. Parkinsonism among Gaucher disease carriers.
Goker-Alpan O; Schiffmann R; LaMarca ME; Nussbaum RL; McInerney-Leo A; Sidransky E
J Med Genet; 2004 Dec; 41(12):937-40. PubMed ID: 15591280
[TBL] [Abstract][Full Text] [Related]
17. Type 2 gaucher disease: an expanding phenotype.
Tayebi N; Stone DL; Sidransky E
Mol Genet Metab; 1999 Oct; 68(2):209-19. PubMed ID: 10527671
[No Abstract] [Full Text] [Related]
18. Gaucher disease, a paradigm for single gene defects.
Beutler E
Experientia; 1995 Mar; 51(3):196-7. PubMed ID: 7698272
[No Abstract] [Full Text] [Related]
19. Gaucher disease in the neonate: a distinct Gaucher phenotype is analogous to a mouse model created by targeted disruption of the glucocerebrosidase gene.
Sidransky E; Sherer DM; Ginns EI
Pediatr Res; 1992 Oct; 32(4):494-8. PubMed ID: 1437405
[TBL] [Abstract][Full Text] [Related]
20. Divergent phenotypes in Gaucher disease implicate the role of modifiers.
Goker-Alpan O; Hruska KS; Orvisky E; Kishnani PS; Stubblefield BK; Schiffmann R; Sidransky E
J Med Genet; 2005 Jun; 42(6):e37. PubMed ID: 15937077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
